Skip to Content

M LN3 (Lamivudine 300 mg)

Pill with imprint M LN3 is White, Elliptical / Oval and has been identified as Lamivudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lamivudine is used in the treatment of hepatitis b; nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LN3

Lamivudine 300 mg M LN3

Lamivudine

Imprint
M LN3
Strength
300 mg
Color
White
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5170
Inactive Ingredients
hypromelloses, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M LN3"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.